Nuwellis, Inc. (NUWE)

Market Cap	2.27M
Revenue (ttm)	8.86M
Net Income (ttm)	-22.63M
Shares Out	6.80M
EPS (ttm)	-11.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,044,888
Open	0.255
Previous Close	0.257
Day's Range	0.251 - 0.357
52-Week Range	0.240 - 5.730
Beta	0.17
Analysts	Hold
Price Target	n/a
Earnings Date	May 7, 2024

About NUWE

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Aus...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 59
• Stock Exchange: NASDAQ
• Ticker Symbol: NUWE

Financial Performance

In 2023, Nuwellis's revenue was $8.86 million, an increase of 3.76% compared to the previous year's $8.54 million. Losses were -$22.63 million, 55.8% more than in 2022.